Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Spencer

Showing results (401-410 of 420) with videos related to

Pageof 42
Sort By:
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Pediatric Research|September 27, 2005
TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndromeDeborah A McDermott, Michael C Bressan, Jie He, et al.
Experimental Hematology|August 2, 2017
Comprehensive discovery of noncoding RNAs in acute myeloid leukemia cell transcriptomesJin Zhang, Malachi Griffith, Christopher A Miller, et al.
Arthritis Care & Research|June 12, 2023
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic ArthritisCatherine A Bingham, Julia G Harris, Tingting Qiu, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
Pageof 42

Showing results (401-410 of 420) with videos related to

Sort By:
Pageof 42
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Pediatric Research|September 27, 2005
TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndromeDeborah A McDermott, Michael C Bressan, Jie He, et al.
Experimental Hematology|August 2, 2017
Comprehensive discovery of noncoding RNAs in acute myeloid leukemia cell transcriptomesJin Zhang, Malachi Griffith, Christopher A Miller, et al.
Arthritis Care & Research|June 12, 2023
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic ArthritisCatherine A Bingham, Julia G Harris, Tingting Qiu, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
Pageof 42